Abstract
Cocaine, like most other drugs of abuse, exerts long lasting changes in gene expression in the reward circuitry of the brain. This resultant remodelled reward circuitry is considered to underlie drug addiction and relapse. In recent years, genome-wide expression studies and epigenomic analysis of the affected regions in the reward circuitry have identified molecular changes associated with the structural remodeling of the circuitry. In particular, application of gene expression microarray and chromatin immunoprecipitation (ChIP) coupled to microarray (ChIP-chip) or sequencing (ChIP-seq) has provided unprecedented insights into the neural and behavioral adaptations in nucleus accumbens (NAc), the critical substrate of the reward circuitry, in cocaine addiction. Genome level expression profiling and epigenomic analysis leading to the recent advances in our understanding of cocaine-induced neural and behavioral adaptations are reviewed here. We examine the convergence of transcriptomic and epigenomic evidence, and discuss about emerging drug target candidates in cocaine-addiction.
Keywords: Addiction, nucleus accumbens, reward circuitry, gene regulatory networks, microarray, ChIP-chip, ChIP-Seq, RNA-Seq, mesolimbic dopamine, cocaine addiction, transcription, oligonucleotide microarrays, post-translational modifications, epigenetic regulatory mechanisms, accumbens genome
Current Psychopharmacology
Title:Insight into Cocaine-Induced Neural and Behavioral Adaptations Using Genome-Wide Expression Profiling and Epigenomic Analysis
Volume: 1
Author(s): Sumana Chakravarty and Arvind Kumar
Affiliation:
Keywords: Addiction, nucleus accumbens, reward circuitry, gene regulatory networks, microarray, ChIP-chip, ChIP-Seq, RNA-Seq, mesolimbic dopamine, cocaine addiction, transcription, oligonucleotide microarrays, post-translational modifications, epigenetic regulatory mechanisms, accumbens genome
Abstract: Cocaine, like most other drugs of abuse, exerts long lasting changes in gene expression in the reward circuitry of the brain. This resultant remodelled reward circuitry is considered to underlie drug addiction and relapse. In recent years, genome-wide expression studies and epigenomic analysis of the affected regions in the reward circuitry have identified molecular changes associated with the structural remodeling of the circuitry. In particular, application of gene expression microarray and chromatin immunoprecipitation (ChIP) coupled to microarray (ChIP-chip) or sequencing (ChIP-seq) has provided unprecedented insights into the neural and behavioral adaptations in nucleus accumbens (NAc), the critical substrate of the reward circuitry, in cocaine addiction. Genome level expression profiling and epigenomic analysis leading to the recent advances in our understanding of cocaine-induced neural and behavioral adaptations are reviewed here. We examine the convergence of transcriptomic and epigenomic evidence, and discuss about emerging drug target candidates in cocaine-addiction.
Export Options
About this article
Cite this article as:
Chakravarty Sumana and Kumar Arvind, Insight into Cocaine-Induced Neural and Behavioral Adaptations Using Genome-Wide Expression Profiling and Epigenomic Analysis, Current Psychopharmacology 2012; 1 (4) . https://dx.doi.org/10.2174/2211556011201040332
DOI https://dx.doi.org/10.2174/2211556011201040332 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Regulation of Neuroimmune-Endocrine Interactions: Mechanisms,Molecular Pathways Unraveled and the Pivotal Role of Cytokines – A Unsung Putative Bidirectional Interdependence between the Immune and Neuroendocrine Interfaces
Current Immunology Reviews (Discontinued) Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Genetic Lipodystrophies: Models for Insulin Resistance
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical Utility of Acarbose, an α-Glucosidase Inhibitor in Cardiometabolic Disorders
Current Drug Metabolism Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) The Effects of Obesity-Related Peptides on the Vasculature
Current Vascular Pharmacology Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer’s and Parkinson’s Diseases
Current Aging Science The Effects of Psychotropic Drugs on the Regulation of Glucose Metabolism
Current Diabetes Reviews Bone Loss and Osteoporosis are Associated with Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
Current Alzheimer Research The Relaxin Peptide Family – Structure, Function and Clinical Applications
Protein & Peptide Letters Recent Advances in the Gastric Mucosal Protection Against Stress-induced Gastric Lesions. Importance of Renin-angiotensin Vasoactive Metabolites, Gaseous Mediators and Appetite Peptides
Current Pharmaceutical Design Proteome Adjustments Post Gradual Hypoxic Stress in Barilius bendelisis: Insights into Adaptive Strategies of a Hill Stream Cyprinid
Current Proteomics Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimers Disease
Current Alzheimer Research Opiates as Antidepressants
Current Pharmaceutical Design Using Mass Spectrometry-Based Peptidomics to understand the Brain and Disorders such as Parkinson’s Disease and Schizophrenia
Current Topics in Medicinal Chemistry Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Leptin Transport Across the Blood-Brain Barrier: Implications for the Cause and Treatment of Obesity
Current Pharmaceutical Design Adrenal Insufficiency Caused by Locally Applied Glucocorticoids-Myth or Fact?
Current Medicinal Chemistry